217 related articles for article (PubMed ID: 22106167)
21. Multimodal approach to ovarian cancer.
Scarfone G; Bolis G
Ann Oncol; 2006 May; 17 Suppl 5():v199-200. PubMed ID: 16807456
[No Abstract] [Full Text] [Related]
22. Malignant ovarian germ-cell tumours.
Low JJ; Ilancheran A; Ng JS
Best Pract Res Clin Obstet Gynaecol; 2012 Jun; 26(3):347-55. PubMed ID: 22301054
[TBL] [Abstract][Full Text] [Related]
23. Germ cell tumors with sarcomatous components: a clinicopathologic and immunohistochemical study of 46 cases.
Malagón HD; Valdez AM; Moran CA; Suster S
Am J Surg Pathol; 2007 Sep; 31(9):1356-62. PubMed ID: 17721191
[TBL] [Abstract][Full Text] [Related]
24. On the road to PARPi-platin.
Bookman MA
J Natl Cancer Inst; 2014 Jun; 106(6):dju119. PubMed ID: 24842884
[No Abstract] [Full Text] [Related]
25. Ovarian cancer: relevant therapy, not timing, is paramount.
Morris RT; Monk BJ
Lancet; 2010 Oct; 376(9747):1120-2. PubMed ID: 20888975
[No Abstract] [Full Text] [Related]
26. Management of ovarian germ cell tumours.
Newlands ES
Forum (Genova); 2000; 10(4):368-80. PubMed ID: 11535986
[TBL] [Abstract][Full Text] [Related]
27. Nondysgerminomatous ovarian tumors: clinical characteristics, treatment, and outcome. A case-controlled study.
Ghaemmaghami F; Hasanzadeh M; Karimi Zarchi M; Fallahi A
Int J Surg; 2008 Oct; 6(5):382-6. PubMed ID: 18715834
[TBL] [Abstract][Full Text] [Related]
28. [Ovarian cancer: the silent tumor. Facts].
Krankenpfl J; 1999; 37(1-2):34-5. PubMed ID: 10401375
[No Abstract] [Full Text] [Related]
29. Updates in the management of ovarian germ cell tumors.
Matei D; Brown J; Frazier L
Am Soc Clin Oncol Educ Book; 2013; ():. PubMed ID: 23714505
[TBL] [Abstract][Full Text] [Related]
30. [Therapy for ovarian cancer--general review].
Ochiai K
Nihon Rinsho; 2004 Oct; 62 Suppl 10():517-21. PubMed ID: 15535299
[No Abstract] [Full Text] [Related]
31. Low-Grade Serous Carcinoma of the Ovary.
Grisham RN
Oncology (Williston Park); 2016 Jul; 30(7):650-2. PubMed ID: 27422112
[No Abstract] [Full Text] [Related]
32. Mucinous adenocarcinoma of the ovary.
Sholi A; Martino MA; Pirigyi M; Rosenblum NG; Markman M; Peterson CS; Bradbury AR; Morris GJ
Semin Oncol; 2010 Aug; 37(4):314-20. PubMed ID: 20816501
[No Abstract] [Full Text] [Related]
33. State-of-the-art first-line treatment of ovarian cancer.
Pfisterer J; Hilpert F; Du Bois A; Meier W; Wagner U
Onkologie; 2003 Oct; 26(5):446-50. PubMed ID: 14605460
[TBL] [Abstract][Full Text] [Related]
34. [Treatment of ovarian cancer].
Cianti C
Clin Ter; 2002; 153(2):135-44. PubMed ID: 12078339
[TBL] [Abstract][Full Text] [Related]
35. Management of recurrent epithelial ovarian carcinoma.
Vasey PA
Aust N Z J Obstet Gynaecol; 2005 Aug; 45(4):269-77. PubMed ID: 16029291
[TBL] [Abstract][Full Text] [Related]
36. Ovarian cancer: a focus on management of recurrent disease.
Herzog TJ; Pothuri B
Nat Clin Pract Oncol; 2006 Nov; 3(11):604-11. PubMed ID: 17080178
[TBL] [Abstract][Full Text] [Related]
37. Outcome and prognostic factors in ovarian germ cell malignancies.
Lai CH; Chang TC; Hsueh S; Wu TI; Chao A; Chou HH; Wang PN
Gynecol Oncol; 2005 Mar; 96(3):784-91. PubMed ID: 15721426
[TBL] [Abstract][Full Text] [Related]
38. [Treatment and prognostic analysis of ovarian cancer patients with isolated region of lymph node recurrence].
Tu H; Huang H; Huang QD; Li Z; Feng YL; Liu JH
Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):928-33. PubMed ID: 23324194
[TBL] [Abstract][Full Text] [Related]
39. [Standard of chemotherapy in ovarian cancer].
Pfleiderer A; Meerpohl HG
Chirurg; 1994 Jan; 65(1):18-22. PubMed ID: 8149794
[No Abstract] [Full Text] [Related]
40. [Therapeutic concept in ovarian cancer].
Rath W; Meden H
Med Klin (Munich); 1991 May; 86(5):263-8. PubMed ID: 1875867
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
